Darren Feldman

Trials

Studies that name Darren Feldman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:48 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05239533 · Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

  Memorial Sloan Kettering Cancer Center · active not recruiting · Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma · principal investigator
• Ph2
  NCT03635892 · A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

  Memorial Sloan Kettering Cancer Center · active not recruiting · Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma · principal investigator
• Ph3
  NCT02375204 · Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

  Alliance for Clinical Trials in Oncology · active not recruiting · Germ Cell Tumor, Teratoma, Choriocarcinoma · study chair
• N/A
  NCT02099734 · Germ Cell Tumor and Testicular Tumor DNA Registry

  Memorial Sloan Kettering Cancer Center · recruiting · Germ Cell Tumor, Testicular Tumor · principal investigator
• Ph2
  NCT01873326 · Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

  Memorial Sloan Kettering Cancer Center · active not recruiting · Germ Cell Tumors · principal investigator
• N/A
  NCT01582204 · Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

  Memorial Sloan Kettering Cancer Center · active not recruiting · Renal Cancer · principal investigator
• N/A
  NCT01453660 · Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls

  Memorial Sloan Kettering Cancer Center · active not recruiting · Germ Cell Cancer · principal investigator
• Ph2
  NCT01399918 · Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

  Memorial Sloan Kettering Cancer Center · completed · Renal Cell Carcinoma · principal investigator
• Ph2
  NCT00957905 · Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

  National Cancer Institute (NCI) · completed · Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor, Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor · principal investigator
• Ph2
  NCT00470366 · Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

  Memorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer · principal investigator
• Ph1/Ph2
  NCT00423852 · Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

  Memorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
  UG1CA233290 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2023 to 2026 · $1,055,000 awarded in 2026
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT02375204
• Cancer Center Administration
  P30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALEX MACDONALD · fiscal years 2014 to 2026
  Named on NCT00957905
• U01CA062491
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00957905
• U01CA062505
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00957905
• U01CA069856
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00957905
• U01CA069912
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00957905
• U01CA099168
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00957905